Gabriella Panuccio

Dr. Gabriella Panuccio

Istituto Italiano di Tecnologia
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2022 in Neuromorphic Computing and Engineering
Verified
Journal Article
Open access
DCDennis V Christensen
Dennis V Christensen
RDRegina Dittmann
Regina Dittmann
BLBernabe Linares-Barranco
Bernabe Linares-Barranco
ASAbu Sebastian
Abu Sebastian
MGManuel Le Gallo
Manuel Le Gallo
NPN Pryds
N Pryds
Modern computation based on von Neumann architecture is now a mature cutting-edge science. In the von Neumann architecture, processing and memory units are implemented as separate blocks interchanging data intensively and continuously. This data transfer is responsible for a large part of the power consumption. The next generation computer technology is expected to solve problems at the exascale with 1018 calculations each second. Even though these future computers will be incredibly powerful, if they are based on von Neumann type architectures, they will consume between 20 and 30 megawatts of power and will not have intrinsic physically built-in capabilities to learn or deal with complex data as our brain does. These needs can be addressed by neuromorphic computing systems which are inspired by the biological concepts of the human brain. This new generation of computers has the potential to be used for the storage and processing of large amounts of digital information with much lower power consumption than conventional processors. Among their potential future applications, an important niche is moving the control from data centers to edge devices. The aim of this roadmap is to present a snapshot of the present state of neuromorphic technology and provide an opinion on the challenges and opportunities that the future holds in the major areas of neuromorphic technology, namely materials, devices, neuromorphic circuits, neuromorphic algorithms, applications, and ethics. The roadmap is a collection of perspectives where leading researchers in the neuromorphic community provide their own view about the current state and the future challenges for each research area. We hope that this roadmap will be a useful resource by providing a concise yet comprehensive introduction to readers outside this field, for those who are just entering the field, as well as providing future perspectives for those who are well established in the neuromorphic computing community.

1 August 2009 in International Journal of Neural Systems
Verified
Journal Article
Closed access
PDF file
JPJoelle Pineau
Joelle Pineau
AGArthur Guez
Arthur Guez
RVRobert Vincent
Robert Vincent
Gabriella PanuccioGabriella Panuccio
Gabriella Panuccio
MAMassimo Avoli
Massimo Avoli

1 April 2010 in Current Opinion in Neurology
Verified
Journal Article
Closed access
Giuseppe BiaginiGiuseppe Biagini
Giuseppe Biagini
Gabriella PanuccioGabriella Panuccio
Gabriella Panuccio
MAMassimo Avoli
Massimo Avoli
Purpose of review Neurosteroids are a family of compounds synthesized directly in the brain by transforming cholesterol into pregnenolone, which is then converted to compounds such as allopregnanolone and allotetrahydrodeoxycorticosterone. In view of their ability to modulate neurotransmission, neurosteroids may influence the clinical course of epileptic disorders. In this review, we highlight two emerging properties of neurosteroids, that is, their anticonvulsant and antiepileptogenic activities. Recent findings It has been shown that fluctuations in neurosteroid synthesis, such as those seen in response to stress or during the ovarian cycle, determine an increase in seizure threshold. Moreover, increased neurosteroid synthesis, presumably occurring in glial cells during epileptogenesis, delays the appearance of recurrent spontaneous seizures in an animal model of temporal lobe epilepsy; such an effect may be due to augmented tonic γ-aminobutyric acid type A receptor-mediated inhibition. Finally, clinical trials with ganaxolone, an allopregnanolone analogue, have demonstrated beneficial effects in pharmacoresistant epileptic patients, whereas finasteride – which interferes with neurosteroid synthesis – facilitates seizures in catamenial epilepsy. Summary The overall evidence suggests that neurosteroids may represent a novel therapeutic strategy in epileptic disorders and a future perspective to control epileptogenicity.

1 March 2017 in Cell Stem Cell
Verified
Journal Article
Closed access
Francesco BifariFrancesco Bifari
Francesco Bifari
IDIlaria Decimo
Ilaria Decimo
APAnnachiara Pino
Annachiara Pino
ELEnric Llorens-Bobadilla
Enric Llorens-Bobadilla
SZSheng Zhao
Sheng Zhao
PCPeter Carmeliet
Peter Carmeliet

1 February 2010 in European journal of pain
Verified
Journal Article
Closed access
ATA. Truini
A. Truini
Gabriella PanuccioGabriella Panuccio
Gabriella Panuccio
FGF. Galeotti
F. Galeotti
MMM.R. Maluccio
M.R. Maluccio
FSF. Sartucci
F. Sartucci
GCG. Cruccu
G. Cruccu

1 June 2005 in Neurobiology of Disease
Verified
Journal Article
Closed access
GDGiovanna D'Arcangelo
Giovanna D'Arcangelo
Gabriella PanuccioGabriella Panuccio
Gabriella Panuccio
VTVirginia Tancredi
Virginia Tancredi
MAM. Avoli
M. Avoli